1. Mean serum concentration time profiles of anifrolumab following subcutaneous and intravenous administration of anifrolumab.a aData below the limits of detection are plotted as one-half of the lower limits of quantification (0.02 µg/mL; dashed line).
Mean serum concentration time profiles of anifrolumab following subcutaneous and intravenous administration of anifrolumab.a aData below the limits of detection are plotted as one-half of the lower limits of quantification (0.02 µg/mL; dashed line). Values are means and SD. IV, intravenous; SC, subcutaneous. 
Raj Tummala et al. Lupus Sci Med 2018;5:e000252
©2018 by Lupus Foundation of America